| Inhibition of IKKɛ and TBK1 improves glucose control in a subset of patients with type 2 diabetes EA Oral, SM Reilly, AV Gomez, R Meral, L Butz, N Ajluni, TL Chenevert, ... Cell metabolism 26 (1), 157-170. e7, 2017 | 152 | 2017 |
| Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort N Ajluni, R Meral, AH Neidert, GF Brady, E Buras, B McKenna, F DiPaola, ... Clinical endocrinology 86 (5), 698-707, 2017 | 81 | 2017 |
| Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities B Akinci, R Meral, EA Oral Current Diabetes Reports 18, 1-12, 2018 | 62 | 2018 |
| Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19 N Şenkal, R Meral, A Medetalibeyoğlu, H Konyaoğlu, M Kose, T Tukek Anatol J Cardiol 24 (1), 21-29, 2020 | 50 | 2020 |
| Metabolic parameters, weight loss, and comorbidities 4 years after Roux-en-Y gastric bypass and sleeve gastrectomy CJ Lager, NH Esfandiari, Y Luo, AR Subauste, AT Kraftson, MB Brown, ... Obesity surgery 28, 3415-3423, 2018 | 42 | 2018 |
| Update on therapeutic options in lipodystrophy B Akinci, R Meral, EA Oral Current Diabetes Reports 18, 1-12, 2018 | 36 | 2018 |
| “Fat shadows” from DXA for the qualitative assessment of lipodystrophy: when a picture is worth a thousand numbers R Meral, BJ Ryan, N Malandrino, A Jalal, AH Neidert, R Muniyappa, ... Diabetes Care 41 (10), 2255-2258, 2018 | 28 | 2018 |
| Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time AW Jalal Eldin, D Tombayoglu, L Butz, A Affinati, R Meral, MS Ontan, ... Clinical Diabetes and Endocrinology 5, 1-7, 2019 | 19 | 2019 |
| Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings B Akinci, A Subauste, N Ajluni, NH Esfandiari, R Meral, AH Neidert, ... Med 2 (7), 814-835. e6, 2021 | 13 | 2021 |
| Cardiac phenotype in familial partial lipodystrophy AJ Eldin, B Akinci, AM da Rocha, R Meral, IY Simsir, SC Adiyaman, ... Clinical endocrinology 94 (6), 1043-1053, 2021 | 10 | 2021 |
| Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis M Sahinoz, S Khairi, A Cuttitta, GF Brady, A Rupani, R Meral, MK Tayeh, ... Clinical Diabetes and Endocrinology 4, 1-6, 2018 | 9 | 2018 |
| The metabolic equivalent BMI in patients with familial partial lipodystrophy (FPLD) compared with those with severe obesity E Koo, MC Foss‐Freitas, R Meral, M Ozer, AJ Eldin, B Akinci, N Miller, ... Obesity 29 (2), 274-278, 2021 | 8 | 2021 |
| Endogenous leptin concentrations poorly predict metreleptin response in patients with partial lipodystrophy R Meral, N Malandrino, M Walter, AH Neidert, R Muniyappa, EA Oral, ... The Journal of Clinical Endocrinology & Metabolism 107 (4), e1739-e1751, 2022 | 7 | 2022 |
| The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide B Akinci, R Meral, D Rus, R Hench, AH Neidert, F DiPaola, M Westerhoff, ... Endocrinology, Diabetes & Metabolism Case Reports 2020 (1), 2020 | 6 | 2020 |
| Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin NH Esfandiari, M Rubenfire, AH Neidert, R Hench, AJ Eldin, R Meral, ... Clinical Diabetes and Endocrinology 5, 1-6, 2019 | 6 | 2019 |
| An open letter to Mehra et al and The New England Journal of Medicine JA Watson, R Meral, R Price, J Simpson Zenodo, 2020 | 5 | 2020 |
| COSMC expression as a predictor of remission in IgA nephropathy SU Akgul, CK Cinar, Y Caliskan, E Demir, E Cebeci, R Meral, S Temurhan, ... International Urology and Nephrology 55 (4), 1033-1044, 2023 | 2 | 2023 |
| MON-101 The LD Lync Study: natural history study of lipodystrophy syndromes: early lessons from the pilot data A Jalal Eldin, B Akinci, R Meral, D Rus, M Swaidan, R Hench, A Neidert, ... Journal of the Endocrine Society 3 (Supplement_1), MON-101, 2019 | 2 | 2019 |
| MON-104 Defining the Contribution of Weight to the Extent of Metabolic Disease in FPLD: Insights from a Retrospective" Matched" Case-Control Study E Koo, R Meral, M Ozer, A Jalal Eldin, N Miller, A Rothberg, E Oral Journal of the Endocrine Society 3 (Supplement_1), MON-104, 2019 | 2 | 2019 |
| Effect of socks on the assessment of vibration sensation RC Meral, Z Matur, B Dertsiz, AE Öge International Scholarly Research Notices 2013, 2013 | 1 | 2013 |
